The hospital LIMM-based clinical pharmacy service improves the quality of the patient medication process and saves time

Eriksson, Tommy; Holmdahl, Lydia; Midlöv, Patrik; Höglund, Peter; Bondesson, Åsa Åb

doi:10.1136/ejhpharm-2012-000096

Cited by 13 publications

(16 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It was estimated that primary physicians spent on average 14.8 min for reviewing the medication list and 4.9 min if the discharging physician at the hospital clinic had to be contacted. 27 The corresponding time in the intervention group was estimated to be 4.7and 2.3 min, respectively.…”

Section: Methodsmentioning

confidence: 99%

“…27 The survey was based on two scenarios with and without an LIMM-discharge information. The average time allocated by a municipality care nurse was estimated to 59 min for patients discharged without a medication report.…”

Section: Methodsmentioning

confidence: 99%

“…The average time allocated by a municipality care nurse was estimated to 59 min for patients discharged without a medication report. 27 For those patients discharged with a medication report, the average time for a nurse was 26 min when inconsistencies between previous medication and the mediation report was found (89%) and 3 min when no inconsistencies were found (11%) (table 1).…”

Section: Methodsmentioning

confidence: 99%

See 2 more Smart Citations

Health economic evaluation of the Lund Integrated Medicines Management Model (LIMM) in elderly patients admitted to hospital

et al. 2013

Self Cite

View full text Add to dashboard Cite

ObjectiveTo evaluate the cost effectiveness of a multidisciplinary team including a pharmacist for systematic medication review and reconciliation from admission to discharge at hospital among elderly patients (the Lund Integrated Medicines Management (LIMM)) in order to reduce drug-related readmissions and outpatient visits.MethodPublished data from the LIMM project group were used to design a probabilistic decision tree model for evaluating tools for (1) a systematic medication reconciliation and review process at initial hospital admission and during stay (admission part) and (2) a medication report for patients discharged from hospital to primary care (discharge part). The comparator was standard care. Inpatient, outpatient and staff time costs (Euros, 2009) were calculated during a 3-month period. Dis-utilities for hospital readmissions and outpatient visits due to medication errors were taken from the literature.ResultsThe total cost for the LIMM model was €290 compared to €630 for standard care, in spite of a €39 intervention cost. The main cost offset arose from avoided drug-related readmissions in the Admission part (€262) whereas only €66 was offset in the Discharge part as a result of fewer outpatient visits and correction time. The reduced disutility was estimated to 0.005 quality-adjusted life-years (QALY), indicating that LIMM was a dominant alternative. The probability that the intervention would be cost-effective at a zero willingness to pay for a gained QALY compared to standard care was estimated to 98%.ConclusionsThe LIMM medication reconciliation (at admission and discharge) and medication review was both cost-saving and generated greater utility compared to standard care, foremost owing to avoided drug-related hospital readmissions. When implementing such a review process with a multidisciplinary team, it may be important to consider a learning curve in order to capture the full advantage.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Health economic evaluation of the Lund Integrated Medicines Management Model (LIMM) in elderly patients admitted to hospital

et al. 2013

Self Cite

View full text Add to dashboard Cite

show abstract

“…Healthcare contacts and hospital readmissions due to medication errors were reduced by at least 50%13 16 but total readmissions were not affected 14. It also saved time, at least 2–3 h per patient, for physicians and nurses in hospitals, in primary and community care 17. The model also generated cost savings of €370, for each intervention cost of €42 and gained utility of 0.005 18.…”

Section: Resultsmentioning

confidence: 97%

“…The probability that the intervention would be cost effective at a zero willingness to pay for a quality adjusted life year gain was 98%. Finally, physicians and nurses were very satisfied with the process and the pharmacist contribution 10 11 17. The model has been adapted to primary care medication review by pharmacists, and a randomised controlled study showed a decrease in potential inappropriate medication among the elderly 19…”

Section: Resultsmentioning

confidence: 99%

Results from a project to develop systematic patient focused clinical pharmacy services. The Lund Integrated Medicines Management model

Eriksson¹

2013

Eur J Hosp Pharm

Self Cite

View full text Add to dashboard Cite

Preliminary feasibility assessment of a targeted, pharmacist-led intervention for older adults with polypharmacy: a mixed-methods study

Liu,

Brokenshire,

Davies

et al. 2024

Int J Clin Pharm

View full text Add to dashboard Cite

Background Polypharmacy is associated with the prescription of inappropriate medications and avoidable medication-related harm. A novel pharmacist-led intervention aims to identify and resolve inappropriate medication prescriptions in older adults with polypharmacy. Aim To conduct a preliminary feasibility assessment of the intervention in primary care, testing whether specific components of the intervention procedures and processes can be executed as intended. Method The mixed-methods study was approved by the New Zealand Health and Disability Ethics Committees and public health agency. Patients from a New Zealand general practice clinic were recruited over 4 weeks to receive the intervention. The preliminary feasibility assessment included measures of intervention delivery, patient-reported outcome measures, and perspectives from ten patients and six clinicians. Data were analysed quantitatively and qualitatively to determine if a full-scale intervention trial is warranted. The study's progression criteria were based on established research and guided the decision-making process. Results The intervention met the study's progression criteria, including patient recruitment, retention, and adherence to the intervention procedures. However, several modifications were identified, including: (1) enhancing patient recruitment, (2) conducting a preliminary meeting between the patient and pharmacist, (3) supporting pharmacists in maintaining a patient-centred approach, (4) reviewing the choice of patient-reported outcome measure, (5) extending the 8-week follow-up period, (6) allocating more time for pharmacists to conduct the intervention. Conclusion The study found the intervention feasible; however, additional development is required before progressing to a full-scale trial. This intervention has the potential to effectively reduce medication-related harm and improve outcomes for older adults with polypharmacy. Trial registration number ACTRN12621000268842 Date registered: 11/03/2021

show abstract

The hospital LIMM-based clinical pharmacy service improves the quality of the patient medication process and saves time

Cited by 13 publications

References 8 publications

Health economic evaluation of the Lund Integrated Medicines Management Model (LIMM) in elderly patients admitted to hospital

Health economic evaluation of the Lund Integrated Medicines Management Model (LIMM) in elderly patients admitted to hospital

Results from a project to develop systematic patient focused clinical pharmacy services. The Lund Integrated Medicines Management model

Preliminary feasibility assessment of a targeted, pharmacist-led intervention for older adults with polypharmacy: a mixed-methods study

Contact Info

Product

Resources

About